Navigation Links
Scientists use an 'ice lolly' to find polar bacteria in their own backyard

To study the bacteria which survive in extreme cold, scientists no longer have to go to extreme environments, such as Antarctic lakes and glaciers. Bacteria previously isolated from polar climates, and have properties which allow them to survive in extreme cold, have been isolated from soil in temperate environments.

Professor Virginia Walker and her colleagues at Queen's University, Canada, have developed a technique to isolate bacteria which have properties to interact with, and modify, ice. This technique involved the formation of an 'ice finger' (or lolly) to select for bacteria which will adsorb to ice. These bacteria were then cultured and identified using their DNA.

The bacteria can modify ice and water in a number of ways. One of the species identified, Chryseobacterium sp., demonstrated Ice Recrystallisation Inhibition (IRI), a property that can be exploited in the production of ice-cream to prevent it from recrystallising and becoming 'crunchy'.

Other species isolated in this study promote the formation of ice crystals at temperatures close to melting, a property which is useful in the production of artificial snow.

Pseudomonas borealis is one species which is not only ice-forming, it is also thought to be tolerant to cold and could therefore have advantages for snow-making in artificial environments such as ski centres and in waste-water purification.

"Selecting for rare microbes that seem to stick to ice has been fun, but now the real work begins to find out what genes are responsible for this attraction" Said Professor Walker.

These findings will decrease the costs involved in the further study of such bacteria and their properties, as scientists will no longer need expeditions to the poles in order to isolate the bugs; they can find them in their own backyards.


'"/>

Source:Blackwell Publishing Ltd.


Page: 1

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists decipher genome of fungus that can cause life-threatening infections
9. Scientists discover the cellular roots of graying hair
10. Scientists rid stem cell culture of key animal cells
11. Scientists develop new color-coded test for protein folding
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: